JP2003506396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506396A5 JP2003506396A5 JP2001514930A JP2001514930A JP2003506396A5 JP 2003506396 A5 JP2003506396 A5 JP 2003506396A5 JP 2001514930 A JP2001514930 A JP 2001514930A JP 2001514930 A JP2001514930 A JP 2001514930A JP 2003506396 A5 JP2003506396 A5 JP 2003506396A5
- Authority
- JP
- Japan
- Prior art keywords
- stirring
- solution
- pure water
- pharmaceutical preparation
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 6
- 239000000825 pharmaceutical preparation Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000725 suspension Substances 0.000 description 4
- -1 beclomethasone dipropionate anhydride Chemical class 0.000 description 3
- 229960000686 benzalkonium chloride Drugs 0.000 description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229940067107 phenylethyl alcohol Drugs 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 229950000210 beclometasone dipropionate Drugs 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9918559.7A GB9918559D0 (en) | 1999-08-07 | 1999-08-07 | Novel pharmaceutical formulation |
| GB9918559.7 | 1999-08-07 | ||
| PCT/JP2000/005200 WO2001010409A1 (en) | 1999-08-07 | 2000-08-03 | Aqueous nasal formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003506396A JP2003506396A (ja) | 2003-02-18 |
| JP2003506396A5 true JP2003506396A5 (https=) | 2007-09-20 |
Family
ID=10858698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001514930A Pending JP2003506396A (ja) | 1999-08-07 | 2000-08-03 | 水性経鼻製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6780398B1 (https=) |
| EP (1) | EP1200066B1 (https=) |
| JP (1) | JP2003506396A (https=) |
| AT (1) | ATE240717T1 (https=) |
| AU (1) | AU6471500A (https=) |
| DE (1) | DE60002885T2 (https=) |
| ES (1) | ES2199845T3 (https=) |
| GB (1) | GB9918559D0 (https=) |
| WO (1) | WO2001010409A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US20050147584A1 (en) * | 2004-01-05 | 2005-07-07 | Allergan, Inc. | Compositions and methods comprising memantine and polyanionic polymers |
| US9808471B2 (en) | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
| US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| ITMI20032054A1 (it) * | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
| CA2550811C (en) * | 2003-12-24 | 2012-05-01 | Jane Hirsh | Temperature-stable formulations, and methods of development thereof |
| EP1645266A1 (en) * | 2004-10-08 | 2006-04-12 | Hisamitsu Medical Co., Ltd. | Aqueous suspension for nasal drops |
| US20060207596A1 (en) * | 2005-03-18 | 2006-09-21 | Fairfield Clinical Trials, Llc | Device and method for delivery of combination nasal medication |
| CN100369608C (zh) * | 2006-03-15 | 2008-02-20 | 修涞贵 | 一种治疗过敏性鼻炎的混悬液型喷雾剂及制备方法 |
| JP5258315B2 (ja) * | 2007-05-25 | 2013-08-07 | ロート製薬株式会社 | フルニソリド含有粘膜適用組成物 |
| US20130213393A1 (en) | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| EP2453872B1 (en) * | 2009-07-17 | 2013-08-21 | Alcon Research, Ltd. | Olopatadine nasal spray regimen for children |
| EP2736491B1 (en) * | 2011-01-04 | 2017-04-05 | Bausch & Lomb Incorporated | Bepotastine compositions |
| EP2704687B1 (en) * | 2011-05-04 | 2015-07-08 | Chiesi Farmaceutici S.p.A. | A topical formulation comprising a corticosteroid as active ingredient |
| BR112014004418A8 (pt) * | 2011-08-25 | 2018-01-23 | Evoke Pharma Inc | método de tratamento de sintomas associados à gastroparesia feminina |
| WO2013049538A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | Allergen nasal compositions |
| WO2013049539A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | A method of blocking or trapping allergens |
| EP3554489A4 (en) | 2016-12-15 | 2020-06-17 | Evoke Pharma, Inc. | TREATMENT FROM MODERATE TO HEAVY GASTROPARESIS |
| AU2022323269A1 (en) * | 2021-08-04 | 2024-02-29 | Indivior Inc. | Compositions and methods for the treatment of opioid overdose |
| WO2025017382A1 (en) * | 2023-07-15 | 2025-01-23 | Aodh Lifesciences Private Limited | Azithromycin nasal spray formulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4782047A (en) * | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
| EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| BR9709650A (pt) * | 1996-06-04 | 1999-08-10 | Procter & Gamble | Aerosol nasal contendo um esteróide intransal e um anti-histamínico |
| GB9806937D0 (en) * | 1998-03-31 | 1998-05-27 | Procter & Gamble | A spray device |
-
1999
- 1999-08-07 GB GBGB9918559.7A patent/GB9918559D0/en not_active Ceased
-
2000
- 2000-08-03 ES ES00951876T patent/ES2199845T3/es not_active Expired - Lifetime
- 2000-08-03 AT AT00951876T patent/ATE240717T1/de not_active IP Right Cessation
- 2000-08-03 US US10/049,167 patent/US6780398B1/en not_active Expired - Lifetime
- 2000-08-03 JP JP2001514930A patent/JP2003506396A/ja active Pending
- 2000-08-03 DE DE60002885T patent/DE60002885T2/de not_active Expired - Lifetime
- 2000-08-03 WO PCT/JP2000/005200 patent/WO2001010409A1/en not_active Ceased
- 2000-08-03 AU AU64715/00A patent/AU6471500A/en not_active Abandoned
- 2000-08-03 EP EP00951876A patent/EP1200066B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003506396A5 (https=) | ||
| EP1227812B1 (en) | Topical nasal treatment using desloratadine and mometasone furoate | |
| KR100211479B1 (ko) | 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제 | |
| JP4603687B2 (ja) | 点鼻用液剤 | |
| JP5042426B2 (ja) | 呼吸器疾患の治療 | |
| EP2075000B1 (en) | Combination of azelastine and ciclesonide | |
| JP2956029B2 (ja) | 点眼液剤 | |
| JP2005521673A5 (https=) | ||
| JPH11286447A (ja) | 気道流路および肺疾患の処置のためのモメタゾンフロエートの使用 | |
| CN102078285A (zh) | 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶 | |
| EP1343472B1 (en) | Thixotropic nasal spray | |
| CN102266392B (zh) | 一种鼻炎药贴 | |
| JP2009519935A5 (https=) | ||
| EP1374856A1 (en) | Oily thixotropic nasal spray | |
| CN103841958A (zh) | 组合物 | |
| US20090325917A1 (en) | Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate | |
| IT8922216A1 (it) | Soluzione acquosa contenente acido cromoglicico e salbutamol, oppure sali farmaceuticamente accettabili | |
| JP2005533076A (ja) | ムコ多糖及びプロピレングリコールを含む鼻用組成物 | |
| MXPA03003750A (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio. | |
| JP2001247446A (ja) | 深層水配合洗浄薬 | |
| MX2013013879A (es) | Formulacionn farmaceutica nasal que comprende fluticasona. | |
| CN102933198B (zh) | 包含曲普坦化合物的制剂 | |
| CN102078612A (zh) | 含有糠酸莫米松和h1受体拮抗剂的鼻用原位凝胶 | |
| CN104721145A (zh) | 一种布佐林胺纳米粒眼用制剂及其制备方法 | |
| CA2076558A1 (en) | Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |